Abstract
Objectives
Renal ischemia/reperfusion (I/R) injury is associated with increased mortality and morbidity rates due to acute renal failure (ARF). Oxidative stress induced with renal I/R injury directly affects glomerular and tubular epithelium through reactive oxygen species. Several studies have been directed to the treatment of renal I/R injury. The aim of this study was to test the attenuation with silymarin (SM) treatment of renal I/R injury-induced morphological changes in the rat kidney.
Methods
A total of 32 adult male Sprague-Dawley rats were evaluated in four groups. Group I (sham), Group II (renal I/R), Group III (renal I/R injury + SM 50 mg per kg) and Group IV (renal I/R injury + SM 100 mg per kg) were designed to evaluate the dose-dependent effects of SM on the morphological changes of renal I/R injury. Renal I/R injury were induced with left renal pedicle occlusion for 45 min followed with reperfusion for 6 h under anesthesia. After induction of I/R injury, left nephrectomies were performed for histopathological examinations.
Results
After renal I/R injury, significant tubular dilatation, tubular vacuolization, pelvic inflammation, interstitial inflammation, perirenal adipose infiltration, tubular necrosis and glomerular necrosis (cortical necrosis) were observed. However, even with low dose SM in Group III (50 mg per kg SM), histopathological changes due to I/R injury were prevented.
Conclusions
The results of this study have demonstrated that SM significantly prevents renal I/R injury-induced renal tubular changes in the rat. SM in 50 mg/kg was observed to be sufficient to significantly prevent renal tubular necrosis. Further, to our literature knowledge, this is the first specific study to demonstrate the preventive effect of SM on renal I/R injury.
Similar content being viewed by others
References
Avlan D, Tamer L, Ayaz L, Polat A, Ozturk C, Ozturhan H, Camdeviren H, Aksoyek S (2006) Effects of trapidil on renal ischemia–reperfusion injury. J Pediatric Surg 41:1686–1693
Thadhani R, Pascual M, Bonvetre JV (1996) Acute renal failure. N Engl J Med 334: 1448–1460
Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494
Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney. A review. Comp Biochem Physiol 142:317–327
Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123:7–13
Sener G, Tugtepe H, Yuksel M, Cetinel S, Gedik N, Yegen BC (2006) Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch Med Res 37:822–829
Gobe G, Johnson DW (2007) Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 39: 1551–1561
Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148
Mora A, Paya M, Rios J, Alcaraz M (1990) Structure activity relationships of polymetoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochem Pharmacol 40:793–794
Zhao B (2005) Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 31:283–294
Karimi G, Ramezani M, Tahoonian Z (2005) Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med 2:383–386
Marubayashi S, Dohi K (1996) Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications. Surg Today 26:573–580
Granger DN, Korthuis RJ (1995) Physiological mechanisms of postischemic tissue injury. Annu Rev Physiol 57:311–332
Zimmerman BJ, Grisham MB, Granger DN (1990) Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258:G185–G190
Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR (1999) Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia–reperfusion. Am J Physiol 277:R922–R929
Weight SC, Bell PR, Nicholson ML (1996) Renal ischemia–reperfusion injury. Br J Surg 83:162–170
Willams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia–reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7
Molitoris BA, Mars J (1999) The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106:583–592
Huang W, Lee SL, Sjöquist M (1995) Natriuretic role of endogenous oxytocin in male rats infused with hypertonic NaCl. Am J Physiol 268:R634–R640
Sehirli AO, Sener G, Satiroglu H, Ayanoglu-Dulger G (2003) Protective effect of N-acetylcysteine on the renal ischemia/reperfusion injury in the rat. J Nephrol 16:75–80
Sener G, Sehirli O, Erkanli G, Cetinel S, Gedik N, Yegen BC (2004) 2-mercaptoethane sulfonate (MESNA) protects against burn-induced renal injury in rats. Burns 30:557–564
Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 9:105–113
Luper S (1998) A review of plants used in the treatment of liver disease: part 1. Alternat Med Rev 3:410–421
Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK (2006) Proinflammatory cytokine-induced NF-kappaB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 103:e156–e165
Kren V, Walterova D (2005) Silybin and silymarin—new effects and applications. Biomed Papers 149:29–41
Sonnenbichler J, Zetl I (1986) Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res 213:319–331
Moscarell S, Giusti A, Marra F, Marena C, Lampertico M, Relli P, Gentilini P, Buzzelli G (1993) Therapeutic and antilipoperoxidant effects of silybin phophatidylcholine complex in chronic liver disease: preliminary results. Curr Therapeut Res 53:1
Farghali H, Kameniková L, Hynie S, Kmonicková E (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41:231–237
Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA (2002) Milk thistle for the treatment of liver disease: a systemic review and meta-analysis. Am J Med 113:506–515
Conflict of interest statement
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Senturk, H., Kabay, S., Bayramoglu, G. et al. Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World J Urol 26, 401–407 (2008). https://doi.org/10.1007/s00345-008-0256-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-008-0256-1